Superparamagnetic iron oxide nanoparticles mediated 131I-hVEGF siRNA inhibits hepatocellular carcinoma tumor growth in nude mice

BMC Cancer

Volumn 14, Issue 1, 2014, Pages

  Chen, Jing ^a   Zhu, Shu ^a   Tong, Liangqian ^b   Li, Jiansha ^a   Chen, Fei ^a   Han, Yunfeng ^a   Zhao, Ming ^a   Xiong, Wei ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

131I; Hepatocellular carcinoma; Small interfering RNA; SPIOs; VEGF

Indexed keywords

ANTINEOPLASTIC AGENT; IODINE VASCULAR ENDOTHELIAL GROWTH FACTOR SMALL INTERFERING RNA I 131; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG CYTOTOXICITY; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG PURITY; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; ISOTOPE LABELING; LIVER CELL CARCINOMA; MAGNETIC FIELD; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR VOLUME; WEIGHT REDUCTION;

ANIMALS; CARCINOMA, HEPATOCELLULAR; FERRIC COMPOUNDS; HEP G2 CELLS; HUMANS; IODINE RADIOISOTOPES; LIVER NEOPLASMS; MAGNETIC FIELD THERAPY; MALE; METAL NANOPARTICLES; MICE; MICE, INBRED BALB C; MICE, NUDE; RANDOM ALLOCATION; RNA, SMALL INTERFERING; VASCULAR ENDOTHELIAL GROWTH FACTOR A; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84896723910     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-14-114     Document Type: Article

References (28)

1. Venook AP, Papandreou C, Furuse J, de Guevara LL. The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. Oncol 2010, 15(Suppl 4):5-13. doi:10.1634/theoncologist.2010-S4-05.
2. Henry JC, Malhotra L, Khabiri H, Guy G, Michaels A, Hanje J, Azevedo M, Bloomston M, Schmidt CR. Best radiological response to trans-arterial chemoembolization for hepatocellular carcinoma does not imply better outcomes. HPB : Offic J Int Hepato Pancreato Biliary Assoc 2013, 15:196-202. doi:10.1111/j.1477-2574.2012.00529.x.
3. Avila MA, Berasain C, Sangro B, Prieto J. New therapies for hepatocellular carcinoma. Oncogene 2006, 25:3866-3884. doi:10.1038/sj.onc.1209550, 10.1038/sj.onc.1209550, 16799628.
4. Talelli M, Rijcken CJ, Lammers T, Seevinck PR, Storm G, van Nostrum CF, Hennink WE. Superparamagnetic iron oxide nanoparticles encapsulated in biodegradable thermosensitive polymeric micelles: toward a targeted nanomedicine suitable for image-guided drug delivery. Langmuir: ACS J Surf Colloids 2009, 25:2060-2067. doi:10.1021/la8036499.
5. Yamaguchi R, Yano H, Iemura A, Ogasawara S, Haramaki M, Kojiro M. Expression of vascular endothelial growth factor in human hepatocellular carcinoma. Hepatology 1998, 28:68-77. doi:10.1002/hep.510280111.
6. Yao DF, Wu XH, Zhu Y, Shi GS, Dong ZZ, Yao DB, Wu W, Qiu LW, Meng XY. Quantitative analysis of vascular endothelial growth factor, microvascular density and their clinicopathologic features in human hepatocellular carcinoma. Hepatobiliary Pancreatic Dis Int: HBPD INT 2005, 4:220-226.
7. Katoh O, Tauchi H, Kawaishi K, Kimura A, Satow Y. Expression of the vascular endothelial growth factor (VEGF) receptor gene, KDR, in hematopoietic cells and inhibitory effect of VEGF on apoptotic cell death caused by ionizing radiation. Canc Res 1995, 55:5687-5692.
8. Chen J, Zhu S, Xie XZ, Guo SF, Tong LQ, Zhou S, Zhao M, Xianyu ZQ, Zhu XH, Xiong W. Analysis of clinicopathological factors associated with bone metastasis in breast cancer. J Huazhong Univ Sci Technol Med Sci = Hua zhong Ke Ji Da Xue Xue Bao Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao Yixue Yingdewen Ban 2013, 33:122-125. doi:10.1007/s11596-013-1083-1.
9. Chen J, Wu H, Han D, Xie C. Using anti-VEGF McAb and magnetic nanoparticles as double-targeting vector for the radioimmunotherapy of liver cancer. Canc Lett 2006, 231:169-175. doi:10.1016/j.canlet.2005.01.024.
10. Raskopf E, Dzienisowicz C, Hilbert T, Rabe C, Leifeld L, Wernert N, Sauerbruch T, Prieto J, Qian C, Caselmann WH, Schmitz V. Effective angiostatic treatment in a murine metastatic and orthotopic hepatoma model. Hepatology 2005, 41:1233-1240. doi:10.1002/hep.20724, 10.1002/hep.20724, 15915456.
11. Tonra JR, Hicklin DJ. Targeting the vascular endothelial growth factor pathway in the treatment of human malignancy. Immunol Invest 2007, 36:3-23. doi:doi:10.1080/08820130600991794, 10.1080/08820130600991794, 17190647.
12. Finn RS, Zhu AX. Targeting angiogenesis in hepatocellular carcinoma: focus on VEGF and bevacizumab. Expert Rev Anticanc Ther 2009, 9:503-509. doi:10.1586/era.09.6.
13. Raskopf E, Vogt A, Sauerbruch T, Schmitz V. siRNA targeting VEGF inhibits hepatocellular carcinoma growth and tumor angiogenesis in vivo. J Hepatol 2008, 49:977-984. doi:10.1016/j.jhep.2008.07.022, 10.1016/j.jhep.2008.07.022, 18845354.
14. Wang X, Yang L, Chen ZG, Shin DM. Application of nanotechnology in cancer therapy and imaging. CA: Canc J Clin 2008, 58:97-110. doi:10.3322/CA.2007.0003.
15. Lunov O, Syrovets T, Büchele B, Jiang X, Röcker C, Tron K, Nienhaus GU, Walther P, Mailänder V, Landfester K, Simmet T. The effect of carboxydextran-coated superparamagnetic iron oxide nanoparticles on c-Jun N-terminal kinase-mediated apoptosis in human macrophages. Biomaterials 2010, 31:5063-5071. doi:10.1016/j.biomaterials.2010.03.023, 10.1016/j.biomaterials.2010.03.023, 20381862.
16. Medarova Z, Pham W, Farrar C, Petkova V, Moore A. In vivo imaging of siRNA delivery and silencing in tumors. Nat Med 2007, 13:372-377. doi:10.1038/nm1486, 10.1038/nm1486, 17322898.
17. Santangelo PJ, Lifland AW, Curt P, Sasaki Y, Bassell GJ, Lindquist ME, Crowe JE. Single molecule-sensitive probes for imaging RNA in live cells. Nat Meth 2009, 6:347-349. doi:10.1038/nmeth.1316.
18. Amarzguioui M, Holen T, Babaie E, Prydz H. Tolerance for mutations and chemical modifications in a siRNA. Nucleic Acids Res 2003, 31:589-595. 10.1093/nar/gkg147, 140512, 12527766.
19. Czauderna F, Fechtner M, Dames S, Aygün H, Klippel A, Pronk GJ, Giese K, Kaufmann J. Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells. Nucleic Acids Res 2003, 31:2705-2716. 10.1093/nar/gkg393, 156727, 12771196.
20. Braasch DA, Paroo Z, Constantinescu A, Ren G, Oz OK, Mason RP, Corey DR. Biodistribution of phosphodiester and phosphorothioate siRNA. Bioorg Med Chem Lett 2004, 14:1139-1143. doi:10.1016/j.bmcl.2003.12.074, 10.1016/j.bmcl.2003.12.074, 14980652.
21. Elbashir SM, Martinez J, Patkaniowska A, Lendeckel W, Tuschl T. Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate. EMBO J 2001, 20:6877-6888. doi:10.1093/emboj/20.23.6877, 10.1093/emboj/20.23.6877, 125328, 11726523.
22. Bolton AEHW. The labeling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating. Biochem 1973, 133:529-539.
23. Azzopardi EA, Ferguson EL, Thomas DW. The enhanced permeability retention effect: a new paradigm for drug targeting in infection. J Antimicrob Chemother 2013, 68:257-274. doi:10.1093/jac/dks379, 10.1093/jac/dks379, 23054997.
24. Greish K. Enhanced permeability and retention (EPR) effect for anticancer nanomedicine drug targeting. Meth Mol Biol 2010, 624:25-37. doi:10.1007/978-1-60761-609-2_3.
25. Chen B, Wu W, Wang X. Magnetic iron oxide nanoparticles for tumor-targeted therapy. Curr Canc Drug Targets 2011, 11:184-189.
26. Lee SJ, Lee HJ, Moon MJ, Vu-Quang H, Lee HJ, Muthiah M, Che HL, Heo SU, Jeong HJ, Jeong YY, Park IK. Superparamagnetic iron oxide nanoparticles-loaded polymersome-mediated gene delivery guided by enhanced magnetic resonance signal. J Nanosci Nanotechnol 2011, 11:7057-7060. 10.1166/jnn.2011.4861, 22103123.
27. Jain TK, Richey J, Strand M, Leslie-Pelecky DL, Flask CA, Labhasetwar V. Magnetic nanoparticles with dual functional properties: drug delivery and magnetic resonance imaging. Biomaterials 2008, 29:4012-4021. doi:10.1016/j.biomaterials.2008.07.004, 10.1016/j.biomaterials.2008.07.004, 2593647, 18649936.
28. He H, David A, Chertok B, Cole A, Lee K, Zhang J, Wang J, Huang Y, Yang VC. Magnetic Nanoparticles for Tumor Imaging and Therapy: A So-Called Theranostic System. Pharmaceut Res 2013, doi:10.1007/s11095-013-0982-y.